Article Abstract

How to identify better candidate to radioembolization in case of hepatocellular carcinoma and portal vein tumoral thrombosis

Authors: Giovanni Battista Levi Sandri, Michel Rayar


Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the fifth most common malignant tumor worldwide. Liver resection is a curative treatment for HCC and can be safety performed by a minimally invasive procedure in all liver segments without size limitations (1,2).